Actavia Life Sciences (Actavia Life Sciences) Dividend Payout Ratio : 0.00 (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Actavia Life Sciences Dividend Payout Ratio?

Actavia Life Sciences's dividend payout ratio for the months ended in Mar. 2024 was 0.00.

The historical rank and industry rank for Actavia Life Sciences's Dividend Payout Ratio or its related term are showing as below:

RASP's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.44
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-06-09), the Dividend Yield % of Actavia Life Sciences is 0.00%.

Actavia Life Sciences's Dividends per Share for the months ended in Mar. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Actavia Life Sciences Dividend Payout Ratio Historical Data

The historical data trend for Actavia Life Sciences's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actavia Life Sciences Dividend Payout Ratio Chart

Actavia Life Sciences Annual Data

Trend

Jun14

Jun15

Jun16

Mar17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Dividend Payout Ratio

Get a 7-Day Free Trial

Actavia Life Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Actavia Life Sciences's Dividend Payout Ratio

For the Biotechnology subindustry, Actavia Life Sciences's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Actavia Life Sciences's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actavia Life Sciences's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Actavia Life Sciences's Dividend Payout Ratio falls into.

Actavia Life Sciences Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Actavia Life Sciences's Dividend Payout Ratio for the fiscal year that ended in Sep. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Sep. 2023 )	/	EPS without NRI (A: Sep. 2023 )
	=	0	/	-0.01
	=	N/A

Actavia Life Sciences's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2024 )	/	EPS without NRI (Q: Mar. 2024 )
	=	0	/	-0
	=	N/A

Actavia Life Sciences (OTCPK:RASP) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Actavia Life Sciences Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Actavia Life Sciences's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Actavia Life Sciences (Actavia Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actavia Life Sciences Inc (OTCPK:RASP) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

420 Lexington Avenue, Suite 2525, New York, NY, USA, 10170

Website

https://www.rasna.com

Rasna Therapeutics Inc is a clinical-stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, mainly focusing on the treatment of leukemia. Its primary indication is Acute Myeloid Leukemia (AML), which may be fatal within weeks to months, has about a 5-year survival rate of only about 25% and very poor prospects for the long-term survival of patients.

Actavia Life Sciences (Actavia Life Sciences) Headlines

No Headlines